Craig Muir

Craig Muir brings to the company more than 25 years of technology development, implementation and application experience across the biotechnology and pharmaceutical industries. As a Partner and Chief Technology Officer at Third Rock Ventures, Muir leads the identification and integration of drug discovery and development technology platforms for companies across Third Rock’s portfolio, provides solutions for developing platform systems to manage R&D and informatics, and contributes to scientific diligence for investment opportunities. Muir has been instrumental in expanding Third Rock’s San Francisco presence to increase access to innovative technologies and support its West Coast companies. He also assumes leadership roles in several of Third Rock’s portfolio companies, serving as Interim Chief Technology Officer or Information Officer through the first 12–18 months after launch. Prior to Third Rock, Muir served as Senior Vice President of Technical Operations for Codon Devices. Before that, he spent 12 years at Millennium Pharmaceuticals as Vice President of Platform Technology, where his teams were instrumental in raising $1.8 billion from pharmaceutical partners. Earlier in his career, he served in a number of technology development and scientific roles at Genentech, Tularik and the University of Vermont. Muir serves on the Scientific Advisory Board of the Bigelow Laboratory for Ocean Sciences. Muir completed his B.S. in animal physiology at the University of California, Davis and is a pioneer in the fields of laboratory automation and technology in biotech and pharmaceutical applications.